3 ms·
Substantially better link: https://www.merck.com/news/merck-and-moderna-announce-phase-3-interpath-001-trial-of-intismeran-autogene-plus-keytruda-met-endpoints
by amluto 2mo ago
Substantially better link:
https://www.merck.com/news/merck-and-moderna-announce-phase-3-interpath-001-trial-of-intismeran-autogene-plus-keytruda-met-endpoints-of-recurrence-free-survival-rfs-and-distant-metastasis-free-survival-dmfs-in-patient/ https://www.merck.com/news/merck-and-moderna-announce-phase-...
Still no actual Phase 3 data presented.
- anotherpaul 2mo agoThis content is geo/IP fenced
- CamelCaseName 2mo agoHope this helps: https://archive.ph/SQQ97 https://archive.ph/SQQ97
- ricardobayes 2mo agoYes, however the trial succeeded. But by "how much", is not yet released. This trial was not against placebo, but the already existing, and effective Keytruda treatment.
- cogman10 2mo agoI believe both were done with Keytruda. Control was Keytruda without the mRNA treatment. So this should answer the question of "how much better is this with the best we currently have".
- unsupp0rted 2mo agoWe're in the dark ages of "effective" at the moment. But now we're starting to get there.